X4 Pharmaceuticals Company
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Total Funding:
119499999
Investor Type:
IPO
Employee Number:
51-100
Last Funding Date:
2021
Funding Status:
IPO
Technology:
Data-driven Technologies
Estimated Revenue:
Less than $1M
Founded Date:
2014
Industry:
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics
Investors Number:
12
Headquarters:
Cambridge, Massachusetts, United States
Last Funding Type:
Post-IPO Equity